TFF
EBS icon

The Family Firm’s Emergent Biosolutions EBS Stock Holding History

The Family Firm’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-184,512
Closed -$185K – 140
2020
Q1 		$185K Buy
+184,512
New +$10.6M 0.08% 126
2019
Q1 		– Sell
-3,415
Closed -$202K – 140
2018
Q4 		$202K Hold
3,415
– – 0.08% 132
2018
Q3 		$225K Buy
+3,415
New +$199K 0.08% 127

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

The Family Firm's EBS Position: Q2 2020 in Review

The Family Firm sold out of Emergent Biosolutions (EBS) in Q2 2020, closing a stake of 184,512 shares — an estimated $185K sold.

The Family Firm first reported a position in EBS in Q3 2018 and held it in 3 quarters. The position peaked at $225K in Q3 2018. 299 funds tracked by Wall St. Rank hold EBS as of Q2 2020.

  • The Family Firm reported no remaining Emergent Biosolutions position as of Q2 2020 after selling out during the quarter.
  • The Family Firm sold 184,512 Emergent Biosolutions shares in Q2 2020, an estimated $185K.
  • The Family Firm first reported a position in Emergent Biosolutions in Q3 2018 and held it in 3 quarters.
  • The Family Firm's Emergent Biosolutions position peaked at $225K in Q3 2018.
  • 299 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2020.

Based on The Family Firm's 13F filing for Q2 2020, filed 10 Aug 2020.